Literature DB >> 21912888

Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors.

Yoshihiko Fujita1, Rafiqul Islam, Kazuko Sakai, Hiroyasu Kaneda, Kanae Kudo, Daisuke Tamura, Keiichi Aomatsu, Tomoyuki Nagai, Hidekazu Kimura, Kazuko Matsumoto, Marco A de Velasco, Tokuzo Arao, Tadashi Okawara, Kazuto Nishio.   

Abstract

Resveratrol (3, 4', 5-trihydroxy-trans-stilbene), a natural phytoalexin found in grapes and wine, has anti-proliferative activity on human-derived cancer cells. In our study, we used a conventional condensation reaction between aldehydes and amines to provide a number of aza-resveratrol (3, 4', 5-trihydroxy-trans- aza-stilbene) derivatives in an attempt to screen for compounds with resveratrol's action but with increased potency. Aza-resveratrol and its hydroxylated derivative (3, 4, 4', 5-tetrahydroxy-trans- aza-stilbene) showed a more enhanced anti-proliferative effect than resveratrol in an MCF-7 breast carcinoma cell line. To identify the cellular targets of the aza derivatives of resveratrol, we conjugated the latter aza-stilbene compound with epoxy-activated agarose and performed affinity purification. Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, was identified as a major target protein in MCF-7 cell lysates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (MALDI-TOF MS). The aza-resveratrol and its hydroxylated derivative, but not resveratrol, were also found to be potent inhibitors of MIF tautomerase activity, which may be associated with their inhibitory effects on MIF bioactivity for cell growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912888     DOI: 10.1007/s10637-011-9749-7

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  48 in total

1.  The 4'-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol.

Authors:  Atsuko Matsuoka; Kenji Takeshita; Ayumi Furuta; Masayasu Ozaki; Kiyoshi Fukuhara; Naoki Miyata
Journal:  Mutat Res       Date:  2002-11-26       Impact factor: 2.433

Review 2.  Resveratrol: from grapevines to mammalian biology.

Authors:  Shazib Pervaiz
Journal:  FASEB J       Date:  2003-11       Impact factor: 5.191

3.  The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis.

Authors:  Mai Tuyet Nguyen; Hongqi Lue; Robert Kleemann; Michael Thiele; Gabriele Tolle; Doris Finkelmeier; Eva Wagner; Andrea Braun; Jürgen Bernhagen
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.

Authors:  Angeles Dios; Robert A Mitchell; Bayan Aljabari; Jodi Lubetsky; KerryAnn O'Connor; Hong Liao; Peter D Senter; Kirk R Manogue; Elias Lolis; Christine Metz; Richard Bucala; David J E Callaway; Yousef Al-Abed
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

5.  Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol.

Authors:  L A Stivala; M Savio; F Carafoli; P Perucca; L Bianchi; G Maga; L Forti; U M Pagnoni; A Albini; E Prosperi; V Vannini
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

6.  Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.

Authors:  M T del Vecchio; S A Tripodi; F Arcuri; L Pergola; L Hako; R Vatti; M Cintorino
Journal:  Prostate       Date:  2000-09-15       Impact factor: 4.104

7.  Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells.

Authors:  K Meyer-Siegler
Journal:  J Interferon Cytokine Res       Date:  2000-09       Impact factor: 2.607

8.  Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation.

Authors:  Eulalia Pozo-Guisado; M Jesús Lorenzo-Benayas; Pedro M Fernández-Salguero
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

9.  The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle.

Authors:  Eulalia Pozo-Guisado; Alberto Alvarez-Barrientos; Sonia Mulero-Navarro; Belen Santiago-Josefat; Pedro M Fernandez-Salguero
Journal:  Biochem Pharmacol       Date:  2002-11-01       Impact factor: 5.858

10.  Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.

Authors:  Thorsten Hagemann; Stephen C Robinson; Richard G Thompson; Kellie Charles; Hagen Kulbe; Frances R Balkwill
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

View more
  8 in total

1.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

Review 2.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

Review 3.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

4.  Crystal structure of (E)-2-hy-droxy-4'-meth-oxy-aza-stilbene.

Authors:  Suchada Chantrapromma; Narissara Kaewmanee; Nawong Boonnak; Kan Chantrapromma; Hazem A Ghabbour; Hoong-Kun Fun
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-07

5.  Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.

Authors:  Yoshihiko Fujita; Satoshi Koinuma; Marco A De Velasco; Jan Bolz; Yosuke Togashi; Masato Terashima; Hidetoshi Hayashi; Takuya Matsuo; Kazuto Nishio
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

Review 6.  Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets.

Authors:  Uzma Saqib; Tanya T Kelley; Siva K Panguluri; Dongfang Liu; Rajkumar Savai; Mirza S Baig; Stephan C Schürer
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

Review 7.  Macrophage migration inhibitory factor involvement in breast cancer (Review).

Authors:  Vincent Richard; Nadège Kindt; Sven Saussez
Journal:  Int J Oncol       Date:  2015-09-24       Impact factor: 5.650

8.  (E)-2-[(2,4,6-Tri-meth-oxy-benzyl-idene)amino]-phenol.

Authors:  Narissara Kaewmanee; Suchada Chantrapromma; Nawong Boonnak; Ching Kheng Quah; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.